A role for paf-acether (platelet-activating factor) in bronchial hyperreactivity?
Jaques Benveniste
Abstract
Jaques Benveniste
Abstract
Paf-acether (platelet-activating factor, 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a potent mediator of inflammation and allergy, synthesized by various cell types. It is noteworthy that IgE-sensitized alveolar macrophages are capable of releasing this mediator which, in turn, induces a platelet-dependent, cyclooxygenase-independent acute bronchoconstriction in the guinea pig, monkey, and man. Indirect evidence suggests that this mediator may also play a role in human asthma as an inducer of bronchial hyperreactivity, but clear definition of its importance in any disease must await study of the effects of specific, selective antagonists.
OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Paf-acether (platelet-activating factor, 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a potent mediator of inflammation and allergy, synthesized by various cell types. It is noteworthy that IgE-sensitized alveolar macrophages are capable of releasing this mediator which, in turn, induces a platelet-dependent, cyclooxygenase-independent acute bronchoconstriction in the guinea pig, monkey, and man. Indirect evidence suggests that this mediator may also play a role in human asthma as an inducer of bronchial hyperreactivity, but clear definition of its importance in any disease must await study of the effects of specific, selective antagonists.
Key concepts: Platelet-activating factor, Bronchoconstriction, Mediator, Immunology, Asthma, Inflammation, Platelet, Allergy